semaj83/ctmatch_classification huggingface dataset:
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Influenza Vaccine, Influenza Parents of guardians of children aged 2-4 on 31st August 2016 (i.e. born September 1st 2011 to August 31st 2014) who receive the flu vaccine at the GP Parents must be aged 18 or over Parents must be fluent in English
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 60.0-999.0,  Depressive Mood week in-house-rehab at an acute geriatric unit ability to take part in assessments understanding German language Informed Consent  anti-depressive medication shorter than 4 weeks before enrollment In-house rehab < 14 days advanced stage of dementia
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-70.0,  Heart Failure With Normal Ejection Fraction Preserved left ventricular systolic function on echocardiography (LVEF>50%) Evidence of diastolic dysfunction by echocardiography (E/e'>15) Symptoms of heart failure NT-proBNP levels >300 pg/ml absence of permanent atrial fibrillation  acute multi-organ failure history of any malignant disease within 5 years diminished functional capacity due to non-cardiac co-morbidities (COPD, PAOD, morbid obesity) pregnancy
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Respiratory Infections Antibiotics General practitioners working in primary care Patients with suspected respiratory tract infection  Patients that have already started an antibiotic
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Vaccination undergraduate and graduate students at the University of Toronto's Leslie Dan Faculty of Pharmacy undergoing flu vaccination  less than 18 years of age or prior participation in the trial
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 65.0-999.0,  eHealth For the participants 1. The participant has a minimum age of 65 years. 2. The participant is living independently or semi-independently at home, service flat or care home. 3. The participant has no subjective memory concern as reported by the participant, informant, or clinician. 4. The participant has a normal brain function documented by scoring above 27 on the MMSE, above 26 on the MOCA and has a score of 0 for the CDR. 5. In the opinion of the investigator, the participant is in stable medical condition and willing and able to perform study procedures in the opinion of the investigator. 6. The participant is fluent in written and verbal Dutch. For the participants with 1. The participant has a minimum age of 65 years. 2. The participant is living independently or semi-independently at home, service flat or care home. 3. In the opinion of the investigator, the participant is in stable medical condition and willing and able to perform study procedures in the opinion of the investigator. 4. The participant is fluent in written and verbal Dutch. 5. For MCI: MCI patients, at baseline, are diagnosed applying Petersen's diagnostic i.e., (1) cognitive complaint, preferably corroborated by an informant; (2) objective cognitive impairment, quantified as performance of more than 1.5 SD below the appropriate mean on the neuropsychological subtests (z-score below -1.5); (3) largely normal general cognitive functioning; (4) essentially intact activities of daily living (ADL) (basic and instrumental activities of daily living (iADL) were determined by a clinical interview with the patient and an informant); and (5) not demented. 6. For AD:Probable AD according to the National Institute on Aging/Alzheimer's Association Diagnostic Guidelines
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-100.0,  Valvular Heart Disease Stenosis and Regurgitation (Diagnosis) Presence of aortic stenosis, mitral or aortic regurgitation at the time of an echocardiography at the "Cliniques Universitaires Saint Luc"
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 21.0-999.0,  Influenza-Like Illness Influenza Adult patients 21 years of age or older Presenting to the BMC main ED or Urgent Care area with influenza-like illness Physician ordered an influenza A/B diagnostic test  Previously enrolled in the study Any Influenza test result already available at the time approached by the ED RA Physician ordered comprehensive multiplex PCR respiratory pathogen assay instead of an initial influenza A/B-only test Unable to give informed consent
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Coverage Rate of Vaccination for Influenza pregnant women older than 18 vaccination records signatetd letter of agreement  younger than 18
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Breastcancer Age > 18 years HER2/neu+ over-expressing breast cancer (IHC 3+ or FISH ≥2.0) Patients who are receiving adjuvant trastuzumab as standard of care treatment Completion of breast cancer therapy (i.e., surgery, radiation, and chemotherapy as appropriate per standard of care for patients' specific cancer) to trastuzumab (Patients on oral hormonal therapy as part of their adjuvant breast cancer treatment will be maintained on their regimens.) Enrollment must occur so that patients' trastuzumab treatment and vaccine schedule overlap for all 6 vaccinations and so that first vaccination occurs after a standard of care Multiple Gated Acquisition Scan (MUGA) ECOG performance status (PS) 0-1 Clinically cancer-free (no evidence of disease; excluding +CTC) If the patient is of childbearing potential, she must be willing to practice adequate contraception through the study treatment period and for 2 months after completion of the injection sites Ability to understand and the willingness to sign a written informed consent document  Clinical and/or radiographic evidence of residual or persistent breast cancer Receiving immunosuppressive therapy to methotrexate or steroids (note: the use of prednisone, or equivalent, <2.0mg/day, is allowed) Tbili >1.8, creatinin >2, hemoglobin <10, platelets <100,000/mm³, WBC <2,000 Active pulmonary disease requiring medication to multiple inhalers Patients may not be receiving any other investigational agents (except with permission of the Lead Principal Investigator) Pregnant or are nursing History of autoimmune disease (patients with vitiligo not excluded) HIV positive Previous or concomitant malignancies at other sites, except effectively treated non- melanoma skin cancers or carcinoma in situ of the cervix or effectively treated malignancy that has been in remission for over 5 years and highly likely to have been cured Other concurrent severe medical problems, unrelated to the malignancy, that would significantly limit full compliance with the study or expose the patient to unacceptable risk
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Stroke A stroke caregiver is eligible to participate in the study if: 1. He / She is a Chinese adult aged 18 or above; 2. He / She has a family member has the first stroke (ischaemic or haemorrhagic stroke) at the age of 50 or above and has been discharged from the acute hospital for no more than 6 months; 3. He / She provides care or being with the stroke survivor for no less than two hours per day after discharge from the acute hospital; 4. He / She reports significant caregiver burden as measured by the 12-item Zarit Burden Interview (a total score ≥ 12). A stroke survivor is eligible to participate in the study if: 1. He / She is a Chinese adult aged 50 or above; 2. He / She has been discharged from the acute hospital for no more than 6 months; 3. His / Her family caregiver participates in this study; 4. He/ She is able to communicate with interventionists and interviewers; 5. He/ She is competent to give written informed consent. Stroke survivors whose caregivers in the intervention group will receive both the intervention and the questionnaire interviews. Stroke survivors whose caregiver in the control group will only need to take part in the questionnaire interview  A stroke caregiver will be excluded from participation if: 1. His / Her family member has a transient ischaemic attack without a major ischaemic or haemorrhagic stroke; 2. His / Her family member with stroke is residing in a residential care facility after discharge from the acute hospital; 3. He / She is diagnosed as having Alzheimer's disease or other dementias; 4. He / She is unable to understand Cantonese. A stroke survivor is not eligible to participate in the study if: 1. He / She is residing in a residential care facility after discharge from the acute hospital; 2. He/ She has a transient ischaemic attack without a major ischaemic or haemorrhagic stroke; 3. His / Her family caregiver refuses to participate in this study; 4. He/ She is not able to communicate with interventionists and interviewers; 5. He/ She is not competent to give written informed consent
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 65.0-999.0,  Cognitive Impairment Dementia Aging Participants in (NCT02422745) who meet the following are eligible to participate in this ancillary study: - 1. Men and women 65 years and older. 2. Willingness to participate. 3. Ability to answer questions by phone  - 1. Participants who are co-enrolled in the WHI Memory Study. 2. Participants with insulin-dependent diabetes. 3. Participants who are unable to complete the baseline cognitive assessments
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Drug Hypersensitivity Patients seen in consultation in allergology department for suspicion of allergy to beta lactamines  patient refusal to take part in the study pregnancy breast feeding women contraindication to provocation test
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Sepsis Newborn Infection Infants admitted to the NICU at participating sites for > 2 days until discharge  Babies requiring contact precautions due to other reasons (as glove based care would be occurring)
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Dental Hygiene years old and older, having a good understanding of French language (read, write, speak, listen) With at least 20 teeth, including 4 first molars and 4 first or second premolars (4 interdental sites between premolars and molars) Patient attending an appointment in a centre participating to the trial Patient able to support treatment Patient affiliated to a health insurance scheme Patient giving his informed consent and accepting the modalities of the study Patient agreeing to attend up to 4 appointments dedicated to the study, during 8 weeks after the initial appointment (motivational interview) Patient in possession of an internet-enabled smartphone or tablet Patient has a personal e-mail address Patient agreeing to be registered within the system of text-based recalls for the duration of the study  Patient having previously benefited from a periodontal therapy (less than 1 year ago) or currently enrolled in a periodontal therapy program Patient having previously benefited from an oral hygiene motivation session less than 1 year ago Patient has had a calculus removal procedure less than 1 month ago Patient bears orthodontic appliances (any kind, for 1 or both arches) Patient bears removable dental prosthesis (any kind, for 1 or both arches) Patient allergic to benzoic acid preservatives (or thought to be) Patient has a high risk of infective endocarditis Patient benefiting from antiaggregant or anticoagulation therapy Patient is haemophilic Patient is unable to answer questions
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 55.0-80.0,  Sedentary Lifestyle Eligible to participate in an aerobic exercise intervention based on the Physical Activity Readiness Questionnaire, and corrected vision of 20/40 Approval from a physician that monitored electrocardiography (ECG) response during a maximal aerobic fitness test that is part of the second study visit described below Exercising less than 60 minutes a week for the past calendar year  Not between the ages of 55 and 80 years old Not fluent in English Score < 20 (out of 30) on the Montreal Cognitive Assessment (MoCA) Inability to comply with experimental instructions Qualify as "high risk" for acute cardiovascular event by the published standards of the American College of Sports Medicine Previous diagnosis of neurological, metabolic, or psychiatric condition, and no previous brain injury associated with loss of consciousness Inability to complete an MRI
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.0-2.0,  Vaccination Mother-child (or caregiver-child) units with child <2 years of age OR Pregnant women  Family does not have cell-phone OR cannot provide informed consent
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Hypertension Subject must provide signed written informed consent Men and women greater than or equal to 18 years of age at Screening Diagnosis of primary (essential) hypertension (HTN) for at least 3 months prior to Screening and have an office SBP Between 145 mmHg and 170 mmHg at Screening and are treatment-naïve; or Between 130 mmHg and 150 mmHg at Screening and are treated with less than or equal to 2 anti hypertensive medications. Anti-hypertensive medications must be stable for greater than or equal to 8 weeks prior to Screening SBP between 145 mmHg and 170 mmHg, inclusive, and DBP less than or equal to 105 mmHg at the Visit after 2-week Run In Period Body mass index between 25 kg/m2 and 45 kg/m2 with the ability to fit the ambulatory blood pressure monitoring (ABPM) cuff per the manufacturer Subject must have a successful ABPM measurement prior to receiving the study drug Women of childbearing potential and non-surgically sterile male subjects who are sexually active must agree to use an approved highly effective form of contraception from the time of informed consent until 30 days post-dose Women of childbearing potential must have a negative serum pregnancy test result at Screening and a negative urine pregnancy test result at the Visit (Day 0)  Known or suspected secondary HTN (eg, renal artery stenosis, pheochromocytoma, Cushing's disease) Office SBP greater than or equal to 171 mmHg and/or office diastolic blood pressure (DBP) greater than or equal to 105 mmHg at the Visit (Day 0) and confirmed by a second measurement (not on the same day), preferably within 1 day Known hypertensive retinopathy (Keith-Wagener Grade 3 or Grade 4) and/or hypertensive encephalopathy History of spontaneous or drug-induced angioedema Clinically significant valvular heart disease or severe aortic stenosis Subjects with symptomatic heart failure (New York Heart Association Class II to Class IV) History of acute coronary syndrome (non-ST elevation myocardial infarction, ST elevation myocardial infarction, and unstable angina pectoris), stroke, or transient ischemic attack within 6 months prior to Screening Known history of malabsorption syndrome, or has undergone gastrointestinal surgery, including bariatric procedures, that induce chronic malabsorption, within 2 years of Screening Treatment with anti-obesity drugs or procedures 3 months prior to Screening (ie, surgery, aggressive diet regimen, etc.), leading to unstable body weight Female who is breast feeding, pregnant, or planning to become pregnant during the study period
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 60.0-999.0,  Cataract Age Related Macular Degeneration Participants in who 1) report a diagnosis of cataract or AMD, or extraction of cataract, and 2) provide written consent to obtain the medical records for the reported endpoint, are eligible for this ancillary study